The global Orally Administered Vaccine market was valued at 2583 million in 2024 and is projected to reach US$ 3881 million by 2031, at a CAGR of 6.1% during the forecast period.
Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection.
The oral vaccine market is driven by the growing demand for convenient and needle-free vaccination options, especially in pediatric and developing regions. Oral vaccines offer advantages like ease of administration, increased patient compliance, and simplified logistics, making them suitable for mass vaccination programs and reaching remote areas with limited healthcare infrastructure. The potential for improved vaccine stability and reduced production costs further contribute to market growth. However, the market also faces challenges, such as the need for enhanced vaccine stability to withstand gastrointestinal conditions and ensuring consistent efficacy across diverse populations. Additionally, regulatory complexities and the requirement for stringent safety and efficacy data can pose obstacles for oral vaccine manufacturers. To succeed in this market, companies must focus on innovative vaccine delivery technologies, conduct robust clinical trials, collaborate with global health agencies, and address public perception and trust in oral vaccine safety and effectiveness.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Orally Administered Vaccine manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Orally Administered Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Administered Vaccine. This report contains market size and forecasts of Orally Administered Vaccine in global, including the following market information:
Global Orally Administered Vaccine market revenue, 2020-2025, 2026-2031, ($ millions)
Global Orally Administered Vaccine market sales, 2020-2025, 2026-2031, (K Units)
Global top five Orally Administered Vaccine companies in 2024 (%)
Total Market by Segment:
Global Orally Administered Vaccine market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Orally Administered Vaccine market segment percentages, by Type, 2024 (%)
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
Global Orally Administered Vaccine market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Orally Administered Vaccine market segment percentages, by Application, 2024 (%)
Public
Private
Global Orally Administered Vaccine market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Orally Administered Vaccine market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orally Administered Vaccine revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Orally Administered Vaccine revenues share in global market, 2024 (%)
Key companies Orally Administered Vaccine sales in global market, 2020-2025 (estimated), (K Units)
Key companies Orally Administered Vaccine sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Orally Administered Vaccine, market overview.
Chapter 2: Global Orally Administered Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Orally Administered Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Orally Administered Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Orally Administered Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Orally Administered Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Orally Administered Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orally Administered Vaccine Overall Market Size
2.1 Global Orally Administered Vaccine Market Size: 2024 VS 2031
2.2 Global Orally Administered Vaccine Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Orally Administered Vaccine Sales: 2020-2031
3 Company Landscape
3.1 Top Orally Administered Vaccine Players in Global Market
3.2 Top Global Orally Administered Vaccine Companies Ranked by Revenue
3.3 Global Orally Administered Vaccine Revenue by Companies
3.4 Global Orally Administered Vaccine Sales by Companies
3.5 Global Orally Administered Vaccine Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Orally Administered Vaccine Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Orally Administered Vaccine Product Type
3.8 Tier 1, Tier 2, and Tier 3 Orally Administered Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Orally Administered Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Orally Administered Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Orally Administered Vaccine Market Size Markets, 2024 & 2031
4.1.2 Rotavirus Vaccine
4.1.3 Cholera Vaccine
4.1.4 Oral Polio Vaccine
4.1.5 Other
4.2 Segment by Type - Global Orally Administered Vaccine Revenue & Forecasts
4.2.1 Segment by Type - Global Orally Administered Vaccine Revenue, 2020-2025
4.2.2 Segment by Type - Global Orally Administered Vaccine Revenue, 2026-2031
4.2.3 Segment by Type - Global Orally Administered Vaccine Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Orally Administered Vaccine Sales & Forecasts
4.3.1 Segment by Type - Global Orally Administered Vaccine Sales, 2020-2025
4.3.2 Segment by Type - Global Orally Administered Vaccine Sales, 2026-2031
4.3.3 Segment by Type - Global Orally Administered Vaccine Sales Market Share, 2020-2031
4.4 Segment by Type - Global Orally Administered Vaccine Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Orally Administered Vaccine Market Size, 2024 & 2031
5.1.2 Public
5.1.3 Private
5.2 Segment by Application - Global Orally Administered Vaccine Revenue & Forecasts
5.2.1 Segment by Application - Global Orally Administered Vaccine Revenue, 2020-2025
5.2.2 Segment by Application - Global Orally Administered Vaccine Revenue, 2026-2031
5.2.3 Segment by Application - Global Orally Administered Vaccine Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Orally Administered Vaccine Sales & Forecasts
5.3.1 Segment by Application - Global Orally Administered Vaccine Sales, 2020-2025
5.3.2 Segment by Application - Global Orally Administered Vaccine Sales, 2026-2031
5.3.3 Segment by Application - Global Orally Administered Vaccine Sales Market Share, 2020-2031
5.4 Segment by Application - Global Orally Administered Vaccine Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Orally Administered Vaccine Market Size, 2024 & 2031
6.2 By Region - Global Orally Administered Vaccine Revenue & Forecasts
6.2.1 By Region - Global Orally Administered Vaccine Revenue, 2020-2025
6.2.2 By Region - Global Orally Administered Vaccine Revenue, 2026-2031
6.2.3 By Region - Global Orally Administered Vaccine Revenue Market Share, 2020-2031
6.3 By Region - Global Orally Administered Vaccine Sales & Forecasts
6.3.1 By Region - Global Orally Administered Vaccine Sales, 2020-2025
6.3.2 By Region - Global Orally Administered Vaccine Sales, 2026-2031
6.3.3 By Region - Global Orally Administered Vaccine Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Orally Administered Vaccine Revenue, 2020-2031
6.4.2 By Country - North America Orally Administered Vaccine Sales, 2020-2031
6.4.3 United States Orally Administered Vaccine Market Size, 2020-2031
6.4.4 Canada Orally Administered Vaccine Market Size, 2020-2031
6.4.5 Mexico Orally Administered Vaccine Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Orally Administered Vaccine Revenue, 2020-2031
6.5.2 By Country - Europe Orally Administered Vaccine Sales, 2020-2031
6.5.3 Germany Orally Administered Vaccine Market Size, 2020-2031
6.5.4 France Orally Administered Vaccine Market Size, 2020-2031
6.5.5 U.K. Orally Administered Vaccine Market Size, 2020-2031
6.5.6 Italy Orally Administered Vaccine Market Size, 2020-2031
6.5.7 Russia Orally Administered Vaccine Market Size, 2020-2031
6.5.8 Nordic Countries Orally Administered Vaccine Market Size, 2020-2031
6.5.9 Benelux Orally Administered Vaccine Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Orally Administered Vaccine Revenue, 2020-2031
6.6.2 By Region - Asia Orally Administered Vaccine Sales, 2020-2031
6.6.3 China Orally Administered Vaccine Market Size, 2020-2031
6.6.4 Japan Orally Administered Vaccine Market Size, 2020-2031
6.6.5 South Korea Orally Administered Vaccine Market Size, 2020-2031
6.6.6 Southeast Asia Orally Administered Vaccine Market Size, 2020-2031
6.6.7 India Orally Administered Vaccine Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Orally Administered Vaccine Revenue, 2020-2031
6.7.2 By Country - South America Orally Administered Vaccine Sales, 2020-2031
6.7.3 Brazil Orally Administered Vaccine Market Size, 2020-2031
6.7.4 Argentina Orally Administered Vaccine Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Orally Administered Vaccine Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Orally Administered Vaccine Sales, 2020-2031
6.8.3 Turkey Orally Administered Vaccine Market Size, 2020-2031
6.8.4 Israel Orally Administered Vaccine Market Size, 2020-2031
6.8.5 Saudi Arabia Orally Administered Vaccine Market Size, 2020-2031
6.8.6 UAE Orally Administered Vaccine Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Orally Administered Vaccine Major Product Offerings
7.1.4 Merck Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.1.5 Merck Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Orally Administered Vaccine Major Product Offerings
7.2.4 GSK Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Orally Administered Vaccine Major Product Offerings
7.3.4 Sanofi Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.3.5 Sanofi Key News & Latest Developments
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Company Summary
7.4.2 Lanzhou Institute Business Overview
7.4.3 Lanzhou Institute Orally Administered Vaccine Major Product Offerings
7.4.4 Lanzhou Institute Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.4.5 Lanzhou Institute Key News & Latest Developments
7.5 Serum Institute
7.5.1 Serum Institute Company Summary
7.5.2 Serum Institute Business Overview
7.5.3 Serum Institute Orally Administered Vaccine Major Product Offerings
7.5.4 Serum Institute Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.5.5 Serum Institute Key News & Latest Developments
7.6 Valneva
7.6.1 Valneva Company Summary
7.6.2 Valneva Business Overview
7.6.3 Valneva Orally Administered Vaccine Major Product Offerings
7.6.4 Valneva Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.6.5 Valneva Key News & Latest Developments
7.7 Shanghai United Cell
7.7.1 Shanghai United Cell Company Summary
7.7.2 Shanghai United Cell Business Overview
7.7.3 Shanghai United Cell Orally Administered Vaccine Major Product Offerings
7.7.4 Shanghai United Cell Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.7.5 Shanghai United Cell Key News & Latest Developments
7.8 Bibcol
7.8.1 Bibcol Company Summary
7.8.2 Bibcol Business Overview
7.8.3 Bibcol Orally Administered Vaccine Major Product Offerings
7.8.4 Bibcol Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.8.5 Bibcol Key News & Latest Developments
7.9 PaxVax
7.9.1 PaxVax Company Summary
7.9.2 PaxVax Business Overview
7.9.3 PaxVax Orally Administered Vaccine Major Product Offerings
7.9.4 PaxVax Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.9.5 PaxVax Key News & Latest Developments
7.10 Vabiotech
7.10.1 Vabiotech Company Summary
7.10.2 Vabiotech Business Overview
7.10.3 Vabiotech Orally Administered Vaccine Major Product Offerings
7.10.4 Vabiotech Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.10.5 Vabiotech Key News & Latest Developments
7.11 Tiantan Biological
7.11.1 Tiantan Biological Company Summary
7.11.2 Tiantan Biological Business Overview
7.11.3 Tiantan Biological Orally Administered Vaccine Major Product Offerings
7.11.4 Tiantan Biological Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.11.5 Tiantan Biological Key News & Latest Developments
7.12 EuBiologics
7.12.1 EuBiologics Company Summary
7.12.2 EuBiologics Business Overview
7.12.3 EuBiologics Orally Administered Vaccine Major Product Offerings
7.12.4 EuBiologics Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.12.5 EuBiologics Key News & Latest Developments
7.13 Panacea Biotec Ltd
7.13.1 Panacea Biotec Ltd Company Summary
7.13.2 Panacea Biotec Ltd Business Overview
7.13.3 Panacea Biotec Ltd Orally Administered Vaccine Major Product Offerings
7.13.4 Panacea Biotec Ltd Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.13.5 Panacea Biotec Ltd Key News & Latest Developments
7.14 Bio-Med
7.14.1 Bio-Med Company Summary
7.14.2 Bio-Med Business Overview
7.14.3 Bio-Med Orally Administered Vaccine Major Product Offerings
7.14.4 Bio-Med Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.14.5 Bio-Med Key News & Latest Developments
7.15 Halfkin Bio-Pharmaceuticals
7.15.1 Halfkin Bio-Pharmaceuticals Company Summary
7.15.2 Halfkin Bio-Pharmaceuticals Business Overview
7.15.3 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Major Product Offerings
7.15.4 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Sales and Revenue in Global (2020-2025)
7.15.5 Halfkin Bio-Pharmaceuticals Key News & Latest Developments
8 Global Orally Administered Vaccine Production Capacity, Analysis
8.1 Global Orally Administered Vaccine Production Capacity, 2020-2031
8.2 Orally Administered Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Orally Administered Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Orally Administered Vaccine Supply Chain Analysis
10.1 Orally Administered Vaccine Industry Value Chain
10.2 Orally Administered Vaccine Upstream Market
10.3 Orally Administered Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Orally Administered Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Orally Administered Vaccine in Global Market
Table 2. Top Orally Administered Vaccine Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Orally Administered Vaccine Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Orally Administered Vaccine Revenue Share by Companies, 2020-2025
Table 5. Global Orally Administered Vaccine Sales by Companies, (K Units), 2020-2025
Table 6. Global Orally Administered Vaccine Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Orally Administered Vaccine Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Orally Administered Vaccine Product Type
Table 9. List of Global Tier 1 Orally Administered Vaccine Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Orally Administered Vaccine Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Orally Administered Vaccine Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Orally Administered Vaccine Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Orally Administered Vaccine Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Orally Administered Vaccine Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Orally Administered Vaccine Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Orally Administered Vaccine Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Orally Administered Vaccine Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Orally Administered Vaccine Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Orally Administered Vaccine Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Orally Administered Vaccine Sales, (K Units), 2026-2031
Table 21. By Region – Global Orally Administered Vaccine Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Orally Administered Vaccine Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Orally Administered Vaccine Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Orally Administered Vaccine Sales, (K Units), 2020-2025
Table 25. By Region - Global Orally Administered Vaccine Sales, (K Units), 2026-2031
Table 26. By Country - North America Orally Administered Vaccine Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Orally Administered Vaccine Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Orally Administered Vaccine Sales, (K Units), 2020-2025
Table 29. By Country - North America Orally Administered Vaccine Sales, (K Units), 2026-2031
Table 30. By Country - Europe Orally Administered Vaccine Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Orally Administered Vaccine Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Orally Administered Vaccine Sales, (K Units), 2020-2025
Table 33. By Country - Europe Orally Administered Vaccine Sales, (K Units), 2026-2031
Table 34. By Region - Asia Orally Administered Vaccine Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Orally Administered Vaccine Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Orally Administered Vaccine Sales, (K Units), 2020-2025
Table 37. By Region - Asia Orally Administered Vaccine Sales, (K Units), 2026-2031
Table 38. By Country - South America Orally Administered Vaccine Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Orally Administered Vaccine Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Orally Administered Vaccine Sales, (K Units), 2020-2025
Table 41. By Country - South America Orally Administered Vaccine Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Orally Administered Vaccine Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Orally Administered Vaccine Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Orally Administered Vaccine Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Orally Administered Vaccine Sales, (K Units), 2026-2031
Table 46. Merck Company Summary
Table 47. Merck Orally Administered Vaccine Product Offerings
Table 48. Merck Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Merck Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Orally Administered Vaccine Product Offerings
Table 52. GSK Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. GSK Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Orally Administered Vaccine Product Offerings
Table 56. Sanofi Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Sanofi Key News & Latest Developments
Table 58. Lanzhou Institute Company Summary
Table 59. Lanzhou Institute Orally Administered Vaccine Product Offerings
Table 60. Lanzhou Institute Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Lanzhou Institute Key News & Latest Developments
Table 62. Serum Institute Company Summary
Table 63. Serum Institute Orally Administered Vaccine Product Offerings
Table 64. Serum Institute Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Serum Institute Key News & Latest Developments
Table 66. Valneva Company Summary
Table 67. Valneva Orally Administered Vaccine Product Offerings
Table 68. Valneva Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Valneva Key News & Latest Developments
Table 70. Shanghai United Cell Company Summary
Table 71. Shanghai United Cell Orally Administered Vaccine Product Offerings
Table 72. Shanghai United Cell Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Shanghai United Cell Key News & Latest Developments
Table 74. Bibcol Company Summary
Table 75. Bibcol Orally Administered Vaccine Product Offerings
Table 76. Bibcol Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Bibcol Key News & Latest Developments
Table 78. PaxVax Company Summary
Table 79. PaxVax Orally Administered Vaccine Product Offerings
Table 80. PaxVax Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. PaxVax Key News & Latest Developments
Table 82. Vabiotech Company Summary
Table 83. Vabiotech Orally Administered Vaccine Product Offerings
Table 84. Vabiotech Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Vabiotech Key News & Latest Developments
Table 86. Tiantan Biological Company Summary
Table 87. Tiantan Biological Orally Administered Vaccine Product Offerings
Table 88. Tiantan Biological Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Tiantan Biological Key News & Latest Developments
Table 90. EuBiologics Company Summary
Table 91. EuBiologics Orally Administered Vaccine Product Offerings
Table 92. EuBiologics Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. EuBiologics Key News & Latest Developments
Table 94. Panacea Biotec Ltd Company Summary
Table 95. Panacea Biotec Ltd Orally Administered Vaccine Product Offerings
Table 96. Panacea Biotec Ltd Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Panacea Biotec Ltd Key News & Latest Developments
Table 98. Bio-Med Company Summary
Table 99. Bio-Med Orally Administered Vaccine Product Offerings
Table 100. Bio-Med Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. Bio-Med Key News & Latest Developments
Table 102. Halfkin Bio-Pharmaceuticals Company Summary
Table 103. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Offerings
Table 104. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Halfkin Bio-Pharmaceuticals Key News & Latest Developments
Table 106. Orally Administered Vaccine Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 107. Global Orally Administered Vaccine Capacity Market Share of Key Manufacturers, 2023-2025
Table 108. Global Orally Administered Vaccine Production by Region, 2020-2025 (K Units)
Table 109. Global Orally Administered Vaccine Production by Region, 2026-2031 (K Units)
Table 110. Orally Administered Vaccine Market Opportunities & Trends in Global Market
Table 111. Orally Administered Vaccine Market Drivers in Global Market
Table 112. Orally Administered Vaccine Market Restraints in Global Market
Table 113. Orally Administered Vaccine Raw Materials
Table 114. Orally Administered Vaccine Raw Materials Suppliers in Global Market
Table 115. Typical Orally Administered Vaccine Downstream
Table 116. Orally Administered Vaccine Downstream Clients in Global Market
Table 117. Orally Administered Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Orally Administered Vaccine Product Picture
Figure 2. Orally Administered Vaccine Segment by Type in 2024
Figure 3. Orally Administered Vaccine Segment by Application in 2024
Figure 4. Global Orally Administered Vaccine Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Orally Administered Vaccine Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Orally Administered Vaccine Revenue: 2020-2031 (US$, Mn)
Figure 8. Orally Administered Vaccine Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Orally Administered Vaccine Revenue in 2024
Figure 10. Segment by Type – Global Orally Administered Vaccine Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Orally Administered Vaccine Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Orally Administered Vaccine Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Orally Administered Vaccine Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Orally Administered Vaccine Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Orally Administered Vaccine Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Orally Administered Vaccine Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Orally Administered Vaccine Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Orally Administered Vaccine Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Orally Administered Vaccine Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Orally Administered Vaccine Revenue Market Share, 2020-2031
Figure 21. By Region - Global Orally Administered Vaccine Sales Market Share, 2020-2031
Figure 22. By Country - North America Orally Administered Vaccine Revenue Market Share, 2020-2031
Figure 23. By Country - North America Orally Administered Vaccine Sales Market Share, 2020-2031
Figure 24. United States Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Orally Administered Vaccine Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Orally Administered Vaccine Sales Market Share, 2020-2031
Figure 29. Germany Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 30. France Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Orally Administered Vaccine Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Orally Administered Vaccine Sales Market Share, 2020-2031
Figure 38. China Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 42. India Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Orally Administered Vaccine Revenue Market Share, 2020-2031
Figure 44. By Country - South America Orally Administered Vaccine Sales, Market Share, 2020-2031
Figure 45. Brazil Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Orally Administered Vaccine Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Orally Administered Vaccine Sales, Market Share, 2020-2031
Figure 49. Turkey Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Orally Administered Vaccine Revenue, (US$, Mn), 2020-2031
Figure 53. Global Orally Administered Vaccine Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Orally Administered Vaccine by Region, 2024 VS 2031
Figure 55. Orally Administered Vaccine Industry Value Chain
Figure 56. Marketing Channels
